The results demonstrated that genetic liability to type 2 diabetes was significantly associated with an elevated risk of 12 gastrointestinal conditions, including gastroesophageal reflux disease, gastric ulcer, acute gastritis, chronic gastritis, irritable bowel syndrome, diverticular disease, acute pancreatitis, cholelithiasis, cholelithiasis with cholecystitis, nonalcoholic fatty liver disease, liver cirrhosis, and ulcerative colitis [70]
If it goes unnoticed or neglected, the medication can be ruined
The tirzepatide compound breaks down under heat stress, potentially resulting in reduced weight management effects even if the medication appears normal
This is where the dilemma arises
Initially used for type 2 diabetes management, it has been found to aid in weight loss by helping control hunger and cravings